DPP-4 inhibition has beneficial effects on the heart after myocardial infarction. (Q51572627)

7 April 2018

title

DPP-4 inhibition has beneficial effects on the heart after myocardial infarction. (English)

1 reference

7 April 2018

main subject

myocardial infarction

1 reference

9

Issei Komuro

1 reference

7 April 2018

Akihiko Kubota

1

1 reference

7 April 2018

Hiroyuki Takano

2

1 reference

7 April 2018

Haixiu Wang

3

1 reference

7 April 2018

Hiroshi Hasegawa

4

1 reference

7 April 2018

Hiroyuki Tadokoro

5

1 reference

7 April 2018

Masanori Hirose

6

1 reference

7 April 2018

Yuka Kobara

7

1 reference

7 April 2018

Tomoko Yamada-Inagawa

8

1 reference

7 April 2018

Yoshio Kobayashi

10

1 reference

7 April 2018

publication date

28 December 2015

1 reference

7 April 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

7 April 2018

volume

91

1 reference

7 April 2018

page(s)

72-80

1 reference

7 April 2018

Chronic heart failure: contemporary diagnosis and management

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

The year in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Treatment for chronic heart failure in the elderly: current practice and problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Dipeptidyl Peptidase IV Inhibition Alters the Hemodynamic Response to Angiotensin-Converting Enzyme Inhibition in Humans With the Metabolic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

The incretin system and cardiometabolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

DPP-4 inhibitors in the treatment of type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

STAT3, a key regulator of cell-to-cell communication in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.026

10.1016/J.YJMCC.2015.12.026

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018